BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25186442)

  • 1. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
    Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
    Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.
    Xu G; Shi H; Ren L; Gou H; Gong D; Gao X; Huang N
    Int J Nanomedicine; 2015; 10():2051-63. PubMed ID: 25844036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticancer effect and mechanism of polymer micelle-encapsulated quercetin on ovarian cancer.
    Gao X; Wang B; Wei X; Men K; Zheng F; Zhou Y; Zheng Y; Gou M; Huang M; Guo G; Huang N; Qian Z; Wei Y
    Nanoscale; 2012 Nov; 4(22):7021-30. PubMed ID: 23044718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RETRACTED: Enhanced antitumor efficacy of 5-fluorouracil loaded methoxy poly(ethylene glycol)-poly(lactide) nanoparticles for efficient therapy against breast cancer.
    Yuan Z; Qu X; Wang Y; Zhang DY; Luo JC; Jia N; Zhang ZT
    Colloids Surf B Biointerfaces; 2015 Apr; 128():489-497. PubMed ID: 25779606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
    Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
    Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.
    Yin P; Wang Y; Qiu Y; Hou L; Liu X; Qin J; Duan Y; Liu P; Qiu M; Li Q
    Int J Nanomedicine; 2012; 7():3961-9. PubMed ID: 22888239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol-conjugated poly(D, L-lactide)-based micelles as a nanocarrier system for effective delivery of curcumin in cancer therapy.
    Kumari P; Muddineti OS; Rompicharla SV; Ghanta P; B B N AK; Ghosh B; Biswas S
    Drug Deliv; 2017 Nov; 24(1):209-223. PubMed ID: 28156164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toward immunosuppressive effects on liver transplantation in rat model: tacrolimus loaded poly(ethylene glycol)-poly(D,L-lactide) nanoparticle with longer survival time.
    Xu W; Ling P; Zhang T
    Int J Pharm; 2014 Jan; 460(1-2):173-80. PubMed ID: 24172796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
    Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
    Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chlorin e6-conjugated poly(ethylene glycol)-poly(d,l-lactide) nanoparticles for photodynamic therapy.
    Kumari P; Rompicharla SVK; Bhatt H; Ghosh B; Biswas S
    Nanomedicine (Lond); 2019 Apr; 14(7):819-834. PubMed ID: 30874479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating acute cystitis with biodegradable micelle-encapsulated quercetin.
    Wang BL; Gao X; Men K; Qiu J; Yang B; Gou ML; Huang MJ; Huang N; Qian ZY; Zhao X; Wei YQ
    Int J Nanomedicine; 2012; 7():2239-47. PubMed ID: 22661886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma.
    Liu XJ; Li L; Liu XJ; Li Y; Zhao CY; Wang RQ; Zhen YS
    Int J Nanomedicine; 2017; 12():5255-5269. PubMed ID: 28769562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer.
    Liu P; Qin L; Wang Q; Sun Y; Zhu M; Shen M; Duan Y
    Biomaterials; 2012 Oct; 33(28):6739-47. PubMed ID: 22763223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
    Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
    J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery.
    Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S
    Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
    Dong Y; Feng SS
    J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encapsulation of chloroquine and doxorubicin by MPEG-PLA to enhance anticancer effects by lysosomes inhibition in ovarian cancer.
    Shao M; Zhu W; Lv X; Yang Q; Liu X; Xie Y; Tang P; Sun L
    Int J Nanomedicine; 2018; 13():8231-8245. PubMed ID: 30584297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic breast tumor cell killing achieved by intracellular co-delivery of doxorubicin and disulfiram via core-shell-corona nanoparticles.
    Tao X; Gou J; Zhang Q; Tan X; Ren T; Yao Q; Tian B; Kou L; Zhang L; Tang X
    Biomater Sci; 2018 Jun; 6(7):1869-1881. PubMed ID: 29808221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of verapamil and doxorubicin by MPEG-PLA to reverse drug resistance in ovarian cancer.
    Zheng W; Li M; Lin Y; Zhan X
    Biomed Pharmacother; 2018 Dec; 108():565-573. PubMed ID: 30243090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.